Ligand Pharmaceuticals
Price & Volume
Stats
See moreOpen | $309.12 |
Previous Close | $316.24 |
Day Range | $308.11-$315.30 |
52W Range | $122.29-$326.63 |
Market Cap | $6.3B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $274.4M |
Revenue Growth (YoY) | 14.1% |
Gross Profit (12 Mos) | $228.2M |
Diluted EPS | $7.68 |
News
See moreYahoo Finance • 22 hours ago
Agenus Shares Rise After Securing Up to $340 Million Financing Package (AGEN)
Yahoo Finance • 7 days ago
CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026?
Yahoo Finance • 8 days ago
CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance • 21 days ago
Ligand Prices Upsized $625 Million Convertible Senior Notes Offering
About
CEO | Mr. Todd C. Davis Ph.D. |
Address | 555 Heritage Drive, Jupiter, FL, United States, 33458 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 47 |